All News
Filter News
Found 1,131 articles
-
MorphoSys AG to Give Company Presentations At Five Investor Conferences in the U.S. and Europe
9/2/2008
-
Sigma-Aldrich Corporation and Atlas Antibodies AB Announce the Release of 2,000 New, Highly-Validated Prestige Antibodies
8/20/2008
-
DSM Biologics and MorphoSys AG to Manufacture Fully Human Antibody
8/12/2008
-
MorphoSys AG Reports Six Months 2008 Results
7/29/2008
-
MorphoSys AG Licenses RapMAT Technology to Astellas Pharma Inc.
7/23/2008
-
Invitation to Q2 2008 Conference Call of MorphoSys AG On July 29, 2008
7/23/2008
-
MorphoSys AG Release: First AbD Serotec Generated HuCAL Antibodies Distributed as Part of Clinical Diagnostic Kits for Autoimmune Diseases by Phadia AB
7/17/2008
-
MorphoSys AG and Integrated BioTherapeutics Provide Update Regarding USAMRIID Biodefense Project
7/16/2008
-
Boehringer Ingelheim Corporation Gains Access to Additional MorphoSys AG Technology
7/9/2008
-
Sigma-Aldrich Corporation Announces Collaboration to Develop Monoclonal Antibodies Under Five Year Agreement
6/20/2008
-
OncoMed Pharmaceuticals, Inc. Extends License Agreement for Use of MorphoSys AG's Core Technology
6/16/2008
-
Daiichi Sankyo Co Ltd. to Buy U3 Pharma for US $234M (150M Euros)
5/21/2008
-
MorphoSys AG Says Schering-Plough Corporation Extends Alliance
5/19/2008
-
MorphoSys AG Announces Re-election of Supervisory Board Members
5/15/2008
-
MorphoSys AG Reports First Quarter 2008 Results
4/29/2008
-
MorphoSys AG Announces Completion of First Dosing in Phase 1 Trial for MOR103 Program
4/28/2008
-
MorphoSys AG and the Leibniz-Institut fur Molekulare Pharmakologie Sign Broad Research Partnership
4/24/2008
-
Daiichi Sankyo Co Ltd. Extends Alliance with MorphoSys AG for Use of HuCAL GOLD to Develop Novel Antibody Therapies
3/26/2008
-
Crucell N.V. and DSM Biologics Announce Additional PER.C6(R) Licensing Agreement with MorphoSys AG
3/17/2008
-
MorphoSys AG Release: AbD Serotec Receives Large Research Antibody Order From Proteomics Specialist Proteomika
3/5/2008